| Name | Title | Contact Details |
|---|
Illinois Bone and Joint Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Illinois Bone and Joint Institute is based in Morton Grove, IL. You can find more information on Illinois Bone and Joint Institute at www.ibji.com
Dci Biologicals Wichita Falls is a Wichita Falls, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Skagit Regional Health includes Skagit Valley Hospital, Skagit Regional Clinics and Cascade Valley Hospital. Skagit Regional Health is a health care leader in Northwest Washington, providing advanced, quality and comprehensive services to the people of our communities. Skagit Valley Hospital is home to the area`s only cardiac catheterization labs and offers advanced heart and vascular care. Skagit Valley Hospital leads the way in comprehensive cancer care and is a network member of the Seattle Cancer Care Alliance, which brings together the talents and research power of Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children`s. Skagit Valley Hospital is licensed for 137 beds, features a full range of services including comprehensive cancer care; surgical services; a Level III Emergency Department; a well-appointed Family Birth Center; comprehensive diagnostics; and advanced heart and vascular care. Skagit Regional Clinics is a network of 19 health care facilities providing primary and specialty outpatient care in north Snohomish, Island and Skagit counties. Cascade Valley Hospital is a 48-bed acute care facility in Arlington, with a free-standing surgery center and wound care center. Cascade Valley Hospital provides acute, critical care, general surgery, a level IV Emergency Department, and Family Birthing Center, plus a wide array of outpatient and diagnostic imaging services. Skagit Regional Health is Skagit County`s largest employer and the third largest public district hospital in the State of Washington.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
Cathedral Healthcare System is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.